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s u m m a r y
Tuberculosis (TB) caused byMycobacterium tuberculosis (Mtb) is the second major cause of death from an
infectious disease worldwide. Recent advances in DNA sequencing are leading to the ability to generate
whole genome information in clinical isolates of M. tuberculosis complex (MTBC). The identiﬁcation of
informative genetic variants such as phylogenetic markers and those associated with drug resistance or
virulence will help barcode Mtb in the context of epidemiological, diagnostic and clinical studies. Mtb
genomic datasets are increasingly available as raw sequences, which are potentially difﬁcult and com-
puter intensive to process, and compare across studies. Here we have processed the raw sequence data
(>1500 isolates, eight studies) to compile a catalogue of SNPs (n ¼ 74,039, 63% non-synonymous, 51.1% in
more than one isolate, i.e. non-private), small indels (n ¼ 4810) and larger structural variants (n ¼ 800).
We have developed the PolyTB web-based tool (http://pathogenseq.lshtm.ac.uk/polytb) to visualise the
resulting variation and important meta-data (e.g. in silico inferred strain-types, location) within
geographical map and phylogenetic views. This resource will allow researchers to identify poly-
morphisms within candidate genes of interest, as well as examine the genomic diversity and distribution
of strains. PolyTB source code is freely available to researchers wishing to develop similar tools for their
pathogen of interest.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY license.
1. Introduction
Tuberculosis (TB) caused byMycobacterium tuberculosis (Mtb) is
an important global health issue, being the second leading cause of
death from an infectious disease worldwide. The World Health
Organisation (WHO) has set the ambitious target of “elimination” of
TB by 2050. Widespread (multi- and extensive) drug resistance and
high HIV prevalence (13% of new infections) are a serious challenge
to effective control [1]. There is an urgent need for better treat-
ments and vaccines, which in turn require a deeper understanding
of the biology of Mtb and epidemiology of TB disease. Knowledge of
the genomic variability among Mtb isolates could result in such
insights, as well as mechanisms of virulence and transmission.
Human TB is caused by bacteria belonging to the M. tuberculosis
complex (MTBC), predominantly M. tuberculosis, Mycobacterium
bovis and Mycobacterium africanum with occasional cases of infec-
tion with Mycobacterium caprae, Mycobacterium microti, Mycobac-
terium pinnipedii, Mycobacterium orygis andMycobacterium canettii
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reported. They are slow growing, lipid rich actinomycetales with
characteristic cell walls conferring natural resistance to many an-
tibiotics. Members of the MTBC are indistinguishable in their
16SrRNA and rpoB genes, recombination does not occur between
strains and have approximately the same genome length; it is their
host speciﬁcity what allows their differentiation [2]. It has been
speculated that MTBC emerged from a common ancestor in the
Horn of Africa and spread with humanmigrations [3e5]. Mtb is the
prevailing cause of human pulmonary disease and six major global
lineages have now been identiﬁed. First sequenced in 1998 [6], Mtb
has a circular genome (size 4.4Mb, GC content 65%) containing 4111
genes. No plasmids and horizontal gene transfer have been
observed after the last common ancestor of MTBC [7]. The genome
is characterised by limited sequence diversity resulting from a low
mutation rate [8]. Insertion sequences are also responsible for
genomic variation among MTBC isolates [9]. It may be said that
drug treatments are driving changes in the Mtb genomes at a faster
rate than any other evolutionary force [10]. In fact, polymorphisms
are elevated in genes relating to antibiotic action as resistance to
anti-TB drugs is caused predominantly by point mutations that
arise spontaneously and are selected during unsatisfactory drug
treatment. Sequential rounds of mutation and selection result in
the emergence of strains resistant to multiple drugs turning TB in
an even more difﬁcult to treat disease.
Over the last two decades, molecular typing methods such as
IS6110-RFLP [11], spoligotyping [12] and MIRU-VNTR [13] have
been applied and revolutionised epidemiology of TB, by providing
insights into the genetic diversity and population structure of MTBC
[14]. Genotyping has been used extensively with epidemiological
data to further understanding of TB [15]. For example, at the indi-
vidual level, cases of recurrence or treatment failure can be
explained in terms of reactivation with the same strain, exogenous
re-infection or due to polyclonal infection [16]. At a population
level, the origins and transmission dynamics of outbreaks can be
determined [17e19]; whilst at a global level, TB genotypic lineages
have been deﬁned and used to monitor their geographical distri-
bution [15]. Nevertheless, standard genotyping methods have
several limitations. First, the repetitive nature of genetic poly-
morphisms used by molecular techniques makes them highly
prone to convergent evolution [20], reducing their usefulness as
phylogenetic markers. Second, the discriminative power differs
between methods, meaning that results from different techniques
are not always comparable [20]. Furthermore, isolates with iden-
tical DNA ﬁngerprints have been reported to harbour signiﬁcant
genomic diversity [21]. Therefore standard genotyping tools, which
are based on less than 1% of the genome, may not be able to
accurately resolve transmission chains and distinguish disease
relapse from exogenous re-infection conclusively. However, SNPs
and other genetic polymorphisms derived from whole-genome
sequencing (WGS) provide enough discriminatory power to
assess population natural variation and predict its hostepathogen
relation including virulence factors, drug susceptibility de-
terminants and immune modulator factors with importance on the
clinical manifestations [16]. Furthermore, due to its low mutation
rate [19] and limited genomic diversity, the application of WGS in
clinical settings is particularly effective for Mtb [22]. With the rapid
decrease in DNA sequencing costs, it is foreseen that WGS will
eventually be accessible and affordable enough to be an alternative
to current lab-based genotyping techniques in the context of
phylogenetic and epidemiological studies [18,19,23e25].
Given the large amount of data being generated on a routine
basis from Mtb WGS projects, efforts must be focused on data
analysis, accessibility, visualisation and utilisation. The TB com-
munity has a number of available web-based databases and tools to
exploit the existing molecular epidemiological data [26], SNP re-
positories [27] and manually-annotated genomes [28]. Neverthe-
less, there is no tool harbouring genetic polymorphisms derived
from WGS projects integrated with geographic distribution, strain
type information and population structure visualisation. To ﬁll this
gap, we have developed PolyTB, a web-based tool to display Mtb
genetic polymorphisms derived from publicly available WGS
datasets. We compile a catalogue of SNPs, small indels and large
deletions by employing the state-of-the-art variation discovery
software [29]. Variants can be investigated through a genome
browser reporting their chromosome coordinates, and aworld map
showing their global allele distribution. Additionally, the con-
struction of phylogenetic trees based on SNPs provides an addi-
tional tool to investigate the population structure. Strain genotype
information is incorporated, allowing the visualisation of associa-
tions of strain types with particular polymorphisms and/or
geographical locations as well as helping correlate easily with
public health epidemiological data. The integration of such data
into tools like PolyTB is required to fully exploit genomic variation,
and potentially boost TB control research through the discovery of
new drug targets, vaccine antigens and diagnostics.
2. Materials and methods
Eight publicly available Mtb WGS datasets (Table 1) were
downloaded from the European Nucleotide Archive (ENA) (http://
www.ebi.ac.uk/ena/). All isolates (n ¼ 1627) had been sequenced
using Illumina paired-end technology (Illumina-GAII or HiSeq
2000), and were aligned to the H37Rv reference genome (Genbank
accession number: NC_000962.3) using BWA [30]. SAMtools/
BCFtools (SAMTOOLS) [31] and GATK [32] were used to call both
SNPs and small indels. Variants were then selected as the
Table 1
Publicly available Mtb WGS datasets included in PolyTB.
Population (reference) ENA accession
number
Sample size/
post-QC
Read
length
Median read
depth
Post-QC
No. SNPs
Samara, Russia [10] ERP000192 329/264 49 61 18,936
Midlands, UK [18] ERP000276 390/390 75 112 19,406
Kampala, Uganda [52] ERP000520 51/51 75 257 8021
Global key strains [4] ERP001731 171/166 75/100 97 29,181
Bilthoven, Netherlands [19] ERP000111 213/153 75/100 39 10,016
Vancouver, Canada [17] SRP002589* 36/24 50 37.5 1026
Lisbon, Portugal (J. Perdigão et al., submitted for publication) ERP002611** 84/81 100 104 6627
Karonga, Malawi (J. Guerra-Assunção et al., in preparation) ERP000436 353/341 75 183 19,285
Overall 1, 627/1470 74,039
A set of 8 whole-genome sequencing (WGS) studies available in the public domain were downloaded from the European Nucleotide Archive (ENA). All samples were
sequenced at the Wellcome Trust Sanger Institute, except * at the Simon Fraser University and ** at the King Abdullah University of Science and Technology (KAUST); all data
generated using Illumina Genome Analyzer II technology, except Malawi (Karonga Study), Portugal (Lisbon) and Uganda (Kampalan Study) obtained using Illumina HiSeq
2000.
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intersection dataset between those obtained from both programs.
Mappability values were calculated along the whole reference
genome using a k-mer length of 50 bp and 0.04% of allowed sub-
stitutionswhilemapping.Non-unique SNP sites (mappability values
greater than one) were ﬁltered out. We called SNP alleles using an
alternative coverage-based approach. A missing call was assigned if
the total coverage at a site didnot reach aminimumof 20 orwhether
none of the four nucleotides accounted for at least 80% of the total
coverage. We plotted the sorted proportion of missing calls for all
isolates and found a clear inﬂexion point at around 15% which was
then used as a quality threshold to ﬁlter samples.
Large deletions (>100 bp) were determined using a combina-
tion of tools based on paired-end, split-read and depth of coverage
approaches. In particular, Breakdancer [33], CREST [34], Pindel [35],
Delly [36] and CNVnator [37] were employed followed by a de novo
assembly-validating strategy. Reads at putative deletions (300 bp)
predicted by all ﬁve tools were extracted from bam ﬁles and sub-
sequently de novo assembled using Velvet [38]. If a derived contig
happened to be split into two parts when mapping it back to the
reference [39,40] with high similarity (>95%), the contig was
considered a cross-junction contig (CJC) [34]. Deletions without at
least one CJC were considered to be false positives and were
therefore discarded. Deletions in PE/PPE genes were ﬁltered out
due to the complexity of such regions. We observed that these
genes are an important source of false positives. All validated de-
letions were gathered and merged when having a mutual overlap
greater than 95%. Secondly we kept only validated deletions sites
predicted by at least two tools or occurring in at least two isolates. A
summary of the bioinformatic pipeline is summarised in
Supplementary Figure 1.
A set of 16 publicly available complete Mtb genomes were
downloaded (Supplementary Table 1). All genomes were aligned
against the H37Rv reference genome (NC_000962.3) using BWA
MEM [41] and variation derived using SAMTOOLS and GATK. SNPs
and small indels were then derived as the intersection dataset
between those obtained from both calling software. Large deletions
in complete genomes were derived with an implemented pipeline
consisting of nucmer, show-diff [42] and AGE software [39].
Strain spoligotypes for all isolates were derived from fastQ ﬁles
using SpolPred [43]. The best-scoring maximum likelihood phylo-
genetic tree was computed with RAxML v7.4.2 [44] using all 74,039
SNP sites spanning the whole genome. PolyTB has been developed
using a combination of PHP, HTML, CSS, JavaScript and Perl code. The
functionality in theGenomeBrowser page ismostly implemented by
PHP code,whereas theGoogleMaps viewemploysmainly JavaScript,
including the Google Maps JavaScript API. The phylogenetic analysis
page required the integration of executables on the server-side and
speciﬁc JavaScript libraries. A genetic distance matrix was pre-
computed using PHYLIP dnadist program from all SNP sites [45].
Trees are computed on the server upon request by distance-based
programs from the PHYLIP package and then displayed on the
browsermakinguse of jsPhyloSVG JavaScript library [46]. Source and
data processing code is available from the corresponding author.
3. Results
A total of 1627 Mtb isolates from 8 studies with available paired
end sequence data (minimum read length 49 bp) were uniquely
aligned to H37Rv (Genbank accession number: NC_000962.3) using
BWA (see Methods, Supplementary 1 for a schematic of the bio-
informatic pipeline). A high quality SNP dataset (n ¼ 74,039) was
attained by ﬁltering the list of SAMTOOLS and GATK consensus
variant calls using genomicmappability criteria. Isolates having less
than 15% SNP missing calls were retained (n ¼ 1470). Both the
spoligotypes and lineages were inferred in silico, using SpolPred
software [43]. All major modern MTBC lineages [47] are repre-
sented, including lineage 1 (East African-Indian (EAI) spoligotype
family, 95 isolates, 6.46%), lineage 2 (Beijing, 246 isolates, 16.73%),
lineage 3 (Central Asian (CAS), 170 isolates, 11.56%) and lineage 4
(715 isolates, of which 119 X, 273 T, 266 LAM, 7 S and 50 H).
Ancestral lineages represented include seventeen M. africanum
cases, 7 from lineage 5 (West African 1 family), 10 from lineage 6
(West African 2 family) and 6 cases of M. bovis. Nearly 15% of iso-
lates (n ¼ 218) had orphan spoligotypes, i.e. they were not previ-
ously described, but were often closely related to known
spoligotypes. Figure 1 shows a radial phylogram for all samples,
rooted on M. bovis. All major MTBC lineages are separated, with
M. bovis, lineage 1, 2, 3, 5 and 6 isolates clustered within discrete
clades, thereby demonstrating the usefulness of SNPs for strain
classiﬁcation. All isolates belonging to lineage 4 are grouped
together, although H, T and LAM samples are dispersed among
different clades as already observed [48].
To highlight the presence of site-speciﬁc lineages, edges in the
tree were colour-coded by geographical location (Supplementary
Figure 2). The majority of studies (7 out of 8) include isolates
belonging to all genetic lineages. In contrast, samples from the
Vancouver (SRP002589) study are grouped within the same clade
(X spoligotype) suggesting they all resulted from the clonal
expansion of the same ancestor [17]. Similarly, a well-delineated
group of Beijing isolates is found to belong exclusively to the
ERP000192 study carried out in Samara, Russia [10]. The
geographical clustering of this sub-group of Beijing isolates corre-
sponds to the “East European” subtype of the Beijing lineage
dominant in that region.
3.1. Polymorphisms detected and incorporated into PolyTB
Of the 74,039 high quality SNPs identiﬁed (GATK/SAMTOOLS
intersection and ﬁltered by mappability), nearly half (48.9%) were
found to be private, namely observed in only one isolate (Figure 2a).
In general, there were few common SNPs with only 4.6% of SNPs
(n ¼ 3418) present in at least 5% of samples. Most of SNPs were
found in coding regions of the genome (median 88.7%) consistent
with these regions comprising 91.4% of Mtb genome. The majority
lead to non-synonymous (NS) changes in amino acids (median
63.0%). Overall, 1050 SNPs were found per sample on average
(range 0e2261 SNPs), corresponding to a median SNP density of 1
SNP per 4.9 kb. SNP density in coding genes (median 0.20, range 0e
0.50 SNPs/kb) was found to be lower than that in intergenic regions
(median 0.27, range 0e0.81 SNPs/kb). Figure 2b shows the SNP
density calculated across all gene functional categories as anno-
tated in Tuberculist (http://tuberculist.epﬂ.ch/). As expected, the
highly polymorphic PE/PPE gene families have more SNP density
than the average coding regions.
We identiﬁed 4820 indel loci of size ranging between 1 and
40 bp as the intersection dataset resulting from comparing SAM-
TOOLS and GATK derived indels. The majority of indels are found in
single isolates (47.5%) (Figure 2c). An average number of 85 small
indels were detected per sample (range 0e199 indels). Both in-
sertions and deletions accounted for an equal proportion of events,
48.8 and 51.2% respectively. Indel density was found to be ﬁve times
smaller in coding genes (median of 1 indel per 83.2 kb) than in non-
coding regions (median of 1 indel per 15.7 kb). As was the case with
SNPs, the PE/PPE gene families have on average greater indel
density than across the rest of coding regions (Figure 2d).
A total number of 800 large deletion loci (median size of 541 bp,
range 100e28,862 bp) were identiﬁed after applying a combination
of SV detection approaches (pair-end, split-read and depth of
coverage) followed by de novo assembly and re-alignment valida-
tion process of candidate regions. The average number of deletions
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per isolate was 18 (range 0e38) corresponding to a median density
of 1 deletion per 232 kb. Deletion density at coding regions,
including those covering whole genes or partially, was 17 times
smaller (1 deletion per 576 kb) than that calculated for non-coding
regions (1 deletion per 34.3 kb).
The validity of polymorphisms was evaluated by considering
known variants extracted from a set of publicly available Mtbwhole
genome sequences (Supplementary Table 1). A total number of
12,887 SNPs, 6749 small indel and 95 large deletion loci were
identiﬁed from whole genome comparisons of 16 complete Mtb
Figure 2. Polymorphism frequency and density plots. (a) SNP frequency bar plot; (b) SNP density plots for all, coding, non-coding and Tuberculist-functional annotated families; (c)
Small indel frequency plot; (d) Indel density plots for all, coding, non-coding and functional-grouped coding indels.
Figure 1. RAxML maximum likelihood phylogenetic tree constructed for all 1470 isolates (spoligotype colour-coded). Radial phylogram representation of the best-scoring
maximum likelihood phylogenetic tree constructed using RAxML software. Samples are colour-coded by spoligotype strain showing a clear correlation of SNP and spoligotype
clustering.
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genomes against the H37Rv reference (see Materials andMethods).
Our set of polymorphisms (WGS-derived variants) was compared
against this validated dataset ﬁnding an overlap of 4814 SNP, 319
indel and 26 deletion loci, namelyWGS-derived variant loci present
in at least one of theMtb complete genomes too. These overlapping
polymorphisms were found to be more frequent (17.2%, 18.4% and
43.4% of samples for SNPs, indels and deletions) than those not
shared with complete genomes (0.3%, 0.6% and 1.0%). Overall, these
results indicate our set of polymorphisms encompass the known
variants at the high stringency imposed in the calling procedure.
3.2. PolyTB and its applications
PolyTB is a web-based resource (http://pathogenseq.lshtm.ac.
uk/polytb) that has been designed to facilitate the exploration of
MTBC genetic variation (74,039 SNPs, 4820 indels and 800 deletion
sites) at a genome and global scale. The tool consists of comple-
mentary and integrated genome browser, map and phylogenetic
views. The genome browser shows SNPs, small indels and large
deletions, colour-coded and displayed at their respective genomic
coordinates for the chromosome region and isolates selected by the
user. Browsing options allow the user to navigate to the genes or
regions of interest, with annotation tracks (top) and sample de-
scriptions (left side) providing context for the variation. Search
functionality has been implemented to enable the investigation of
polymorphisms at genes of interest given their locus tag, functional
annotation, description key words or association with anti-TB drug
resistance [28]. Figure 3 shows differences on polymorphism pat-
terns between isolates from two different populations in the
neighbouring rpoB and rpoC genes, a region associated with
rifampicin resistance. Known rifampicin resistance markers
including rpoB-516 (corresponding to the observed 761,110 bp
A/ T SNP), rpoB-526 (761,139 bp G/ T and 761,140 bp A/ G)
and rpoB-531 (761,155 bp C / G mutation) are observed in
Ugandan isolates. They all correspond to NS point mutations
included in diagnostic tests [49]. Across all populations there are 65
(44 NS) and 85 (56 NS) SNP loci in rpoB and rpoC genes, respec-
tively. Users may also consider surveying genomic variants in genes
with great importance for the evolution of infection and treatment
outcome such as those associated with virulence, nitric oxide
production and apoptosis among other possibilities.
The PolyTB markers could be considered in functional experi-
ments or used to develop a high throughput genotypic assay for a
large-scale association studyof drug resistance. Overall, the browser
view aims to provide a visualisation tool for the identiﬁcation of
differential variationpatterns among isolates and populations at the
same region or between different regions under study.
The map view shows the global allele distribution for a poly-
morphism of interest. Allelic frequencies for the chosen poly-
morphism are displayed as pie charts at the geographical regions
from where sequenced samples were collected, either alone or
combined with spoligotype frequencies as concentric pies. In the
Figure 3. Polymorphisms at the rpoB-rpoC region associated with rifampicin resistance (Browser View). Genetic variants are shown at the rpoB and rpoC genes, loci known to be
associated with rifampicin resistance. Synonymous SNPs (sSNPs) are coloured in black, non-synonymous SNPs (nsSNPs) in red and small insertions and deletions in blue and green,
respectively. Cursor movement over variants displays an information box with further annotation including nucleotide, codon and amino acid changes for SNPs; and length and
sequence for indels. Locations and Spoligotypes tracks are placed as colour-coded vertical bars at the left hand side of the genomic plot and provide information for samples. Sixty
isolates are shown, 30 from Malawi (colour-coded in red in the Location bar) and 30 from Uganda (shown in green). Patterns of SNP difference can be observed when comparing
isolates from different populations: Kampala isolates harbour many more nsSNPs at rpoB gene than Malawian isolates. The observed nsSNPs are likely to be the underlying cause of
rifampicin resistance (Clark et al., 2013). In fact, rpoB-516 (A/ T SNP at 761,110 bp), rpoB-526 (G/ T 761,139 bp and A/ G 761,140 bp) and rpoB-531 (C/ G 761,155 bp) mutations
are observed in Ugandan isolates, and correspond to nsSNPs already reported as rifampicin resistance markers [28].
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latter, outer arc-sections illustrating strain types are placed on the
top of allele frequencies to visually inform of strain type associations
with variants at the geographical region investigated. Figure 4 shows
an informative SNP (position 4,411,016) found to be associated with
lineage 1 (EAI spoligotype family) across studies (only Tanzania and
Karonga (Malawi) populations shown). Themainpurpose of themap
view is to provide a tool to assess the spread and frequency of WGS-
derived genomic variants at a global scale as well as to enable the
identiﬁcation of population- and strain speciﬁc polymorphisms.
The phylogenetic view allows the user to construct phylogenies
for a subset of isolates using whole-genome spanning SNPs. Spo-
ligotypes are included to investigate whether clustering based on
SNPs correlates with a strain-type. Figure 5 shows the resulting
SNP-based neighbour-joining phylogenetic tree constructed for 140
isolates belonging to four different locations. Other PHYLYP
distance-based methods (Fitch-Margoliash, UPGMA and Least
Squares) are available too. Lineages and locations are shown as
colour-coded bar charts around the tree to highlight the correlation
between lineage and locationwith phylogenetic clustering. The aim
of the phylogenetic view is to assess the genetic relatedness of
isolates within and across populations as well as comparing genetic
clustering with spoligotype and geographical assignation.
The PolyTB views are linked. For example, the map view is
opened for a speciﬁc variant position when such a position is
double-clicked on the browser view. Likewise, PolyTB is linked to
external databases. Drug resistance genes were extracted from
TBDreamDB [28], a database describing common mutations asso-
ciatedwith drug resistance inMtb. Furthermore, if a particular gene
is double-clicked on the top annotation track in the browser view,
the user will be forward to its Tuberculist (http://tuberculist.epﬂ.
ch/) entry page containing further annotation information.
4. Discussion
Rapid, low-cost genome sequencing is expected to have a huge
impact on molecular epidemiology, enabling researchers to gain
insights at patient, community and global levels [16,18,19]. In
addition to tracking the spread of pathogens, WGS is proving to be a
valuable tool to carry out microbial evolution studies over different
time and space scales, within a single patient over months or years;
or globally across centuries [50]. Given the cost decline witnessed
in recent years [23], it is foreseen that WGS will eventually be the
technology of choice in clinical settings, and for epidemiological
and evolutionary studies [16,19].
Although the TB community have availableweb-based databases
to exploit the existing genotyping data for MTBC [51], there is no
such tool gathering the increasing amount of genetic poly-
morphisms derived fromWGSprojects [27]. Given themagnitude of
the genomic data being generated on a routine basis, effortsmust be
focused on analysing and presenting this data in a robust and useful
manner for the research and public health communities. In this
sense, the present release of PolyTBmakes it the largest open-access
repository of genetic polymorphisms derived from WGS projects.
For example, we include overw70 k SNPs (51.1% observed in more
than one isolate), at least 10-foldmore than any other database. The
expandable database goes beyond SNPs, and includes small indels
Figure 4. SNP associated with lineage 1 (EAI) in Tanzanian and Malawian populations (Map view). Allele frequencies are shown for the chosen polymorphic position as pie charts,
either alone or combined with in silico inferred spoligotypes (Coll et al., 2012) to allow the visual detection of relationships between certain alleles and strain types. Reference allele
frequency portions on pie charts are coloured in blue while alternative allele (i.e. non-reference) frequencies are shown in red. Outer chart portions representing relative strain type
frequencies are colour-coded by main spoligotype families (AFRI, BOV, Beijing, CAS, EAI, LAM, Manu, S, T and X). In this particular case, the SNP at 4,411,016 bp position is found to be
associated with lineage 1 (EAI) strains in Tanzania and Karonga (Malawi) populations, visualised as the red portion of the inner pie chart linking with the purple portions of the
outer pie in both settings.
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and large deletions derived by employing the state-of-the-art vari-
ation discovery software. Robust quality control and standardised
procedures applied across samples ensures that the datasets are
directly comparable. Overall we found that small indel and large
deletion densities in coding genes were 5 and 17 times smaller than
in non-coding regions respectively. This considerable reduction in
polymorphism density at coding regions can be explained in terms
of the potential deleterious effects of these variants in the genome,
leading to their selective removal by purifying selection.
PolyTB consists of three complementary and integrated views
with links to other TB databases [27]. The browser view will allow
researchers to investigate genomic diversity within regions or
genes of interest, such as host-infection and drug resistance related
loci, as well as visualise differential variation patterns among iso-
lates at the same region or between different regions under study.
Although Mtb strains were historically conﬁned to their endemic
geographical locations, migration has led to a more global distri-
bution. Modern modes of transport mean that TB is now easily
spread across regions and continents. It is possible to monitor the
spread of Mtb lineages through phylogenetic markers as well as
track drug resistance markers, which emerge de novo and inde-
pendently of strains, with a discriminatory power never achieved
before. In this context, the map view provides a tool for the
epidemiological surveillance of tuberculosis through the
geographic distribution of strains and clinically important genetic
variants, such as those driving drug resistance. Indeed, knowledge
of transmission across lineages and continents is essential to those
who need to devise national prevention and control programmes.
Similarly, themain purpose of the phylogenetic view is to assess the
genetic relatedness of isolates within and across studies as well as
comparing genetic clustering with traditional spoligotypes and
lineages.
Ongoing work is investigating strain-speciﬁc polymorphisms,
variants associated with drug resistance, and the de novo assembly
of poorly characterised regions, including those related to host-
immunology (e.g. PE and PPE families). These results, new data-
sets, provision of meta data such as phenotypes, and novel SV dis-
covery pipelineswill be incorporated into future versions of the tool.
Overall, the high global burden of TB requires new control in-
sights from the increasing number of MtbWGS studies. Knowledge
of the genetic diversity across populations, among other factors,
will assist in the understanding of Mtb biology, required to develop
new drugs and novel vaccines. In this context, PolyTB aims to bring
together all existing genomic diversity into an integrated database
and make it available for the TB community. The underlying source
code is also available increasing the utility amongst researchers
aiming to build similar sites for their pathogen of interest.
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Figure 5. SNP-based neighbour-joining phylogenetic tree of 140 isolates belonging to four different locations (Phylogenetic view) A neighbour phylogenetic tree based on pre-
calculated SNP distances is built in real time for the set of 140 isolates from Shanghai (China), Hamburg (Germany), Karonga (Malawi) and Kampala (Uganda). Spoligotype line-
ages and locations are colour-coded as bar charts around the tree (outer bar representing locations and the inner one spoligotypes) to enable the visual identiﬁcation of correlations
between spoligotype/location and phylogenetic clustering. A table summarising all colour codes will be shown at the left hand side of the page.
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Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.tube.2014.02.005.
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